Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28202
Title: Activation of AMPK reduces the co-transporter activity of NKCC1.
Austin Authors: Fraser, Scott A;Davies, Matthew R P ;Katerelos, Marina ;Gleich, Kurt;Choy, Suet-Wan ;Steel, Rohan;Galic, Sandra;Mount, Peter F ;Kemp, Bruce E;Power, David A 
Affiliation: Institute for Breathing and Sleep
Issue Date: May-2014
Date: 2014-04
Publication information: Molecular Membrane Biology 2014;31(2-3): 95-102
Abstract: The co-transporter activity of Na(+)-K(+)-2Cl(-) 1 (NKCC1) is dependent on phosphorylation. In this study we show the energy-sensing kinase AMPK inhibits NKCC1 activity. Three separate AMPK activators (AICAR, Phenformin and A-769662) inhibited NKCC1 flux in a variety of nucleated cells. Treatment with A-769662 resulted in a reduction of NKCC1(T212/T217) phosphorylation, and this was reversed by treatment with the non-selective AMPK inhibitor Compound C. AMPK dependence was confirmed by treatment of AMPK null mouse embryonic fibroblasts, where A-769662 had no effect on NKCC1 mediated transport. AMPK was found to directly phosphorylate a recombinant human-NKCC1 N-terminal fragment (1-293) with the phosphorylated site identified as S77. Mutation of Serine 77 to Alanine partially prevented the inhibitory effect of A-769662 on NKCC1 activity. In conclusion, AMPK can act to reduce NKCC1-mediated transport. While the exact mechanism is still unclear there is evidence for both a direct effect on phosphorylation of S77 and reduced phosphorylation of T212/217.
URI: https://ahro.austin.org.au/austinjspui/handle/1/28202
DOI: 10.3109/09687688.2014.902128
Journal: Molecular Membrane Biology
PubMed URL: 24702155
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/24702155/
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

24
checked on May 29, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.